No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".
None.
None.
No insider has filed a notice of proposed sale (Form 144) for RAPT Therapeutics, Inc. in the last 12 months.
No 13F manager reports holding RAPT Therapeutics, Inc..
| Fund | Position value | Shares | % of company | % of the fund | As of |
|---|---|---|---|---|---|
|
BE
BlackRock Large Cap Series Funds, Inc.
|
$36M | 620.5K | 2.24% | 0.73% | February 27, 2026 |
|
VT
Vanguard Index Funds
|
$28M | 827.0K | 2.98% | 0.00% | December 31, 2025 |
23 more funds behind a free account
See every fund holding RAPT Therapeutics, Inc. and how much of the fund the position is.
Sign up free| Holder | Shares | % of company | Change vs last qtr | 8 quarters | Held since | % of their book |
|---|---|---|---|---|---|---|
|
PS
Peter Svennilson
5%+ holder
13D · 4.9%
|
1.6M | 5.79% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
|
DV
David V. Goeddel
5%+ holder
13D · 4.9%
|
1.6M | 5.79% | — | — |
— | — |
|
This holder reports through Schedule 13D/G, not a quarterly 13F.
|
||||||
11 more holders behind a free account
See every insider and 5%+ holder of RAPT Therapeutics, Inc..
Sign up freeLoading...